Kiniksa Pharmaceuticals International, plc (KNSA)
NASDAQ: KNSA · Real-Time Price · USD
74.61
-1.12 (-1.48%)
At close: Sep 30, 2026, 4:00 PM EDT
75.35
+0.74 (0.99%)
Pre-market: Oct 1, 2026, 4:00 AM EDT
KNSA Market Cap
KNSA has a market cap or net worth of $5.82 billion as of September 30, 2026. Its market cap has increased by 102.61% in one year.
Market Cap
5.82B
Enterprise Value
5.30B
1-Year Change
102.61%
Ranking
Category
Stock Price
$74.61
ChartMarket Cap Chart
Since May 24, 2018, KNSA's market cap has increased from $914.40M to $5.82B, an increase of 536.63%. That is a compound annual growth rate of 24.79%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 30, 2026 | 5.82B | 86.19% |
| Dec 31, 2025 | 3.13B | 118.93% |
| Dec 31, 2024 | 1.43B | 15.76% |
| Dec 29, 2023 | 1.23B | 18.44% |
| Dec 30, 2022 | 1.04B | 28.47% |
| Dec 31, 2021 | 810.80M | -32.60% |
| Dec 31, 2020 | 1.20B | 98.17% |
| Dec 31, 2019 | 607.00M | -56.32% |
| Dec 31, 2018 | 1.39B | 51.96% |
| May 24, 2018 | 914.40M | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Neurocrine Biosciences | 14.28B |
| Elanco Animal Health | 11.22B |
| Dr. Reddy's Laboratories | 10.61B |
| Amneal Pharmaceuticals | 7.14B |
| Alkermes | 6.74B |
| Hims & Hers Health | 6.71B |
| Liquidia | 6.59B |
| Lantheus Holdings | 6.51B |